StonvexLoading…
StonvexStonvexStonvexCore line items from BIRD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $152.47M | $189.76M | $254.06M | $297.77M |
Operating Income | $-79.96M | $-97.55M | $-153.00M | $-100.28M |
Net Income | $-77.28M | $-93.32M | $-152.46M | $-101.35M |
EPS (Diluted) | $-9.47 | $-11.87 | $-20.10 | $-0.68 |
Total Assets | $109.42M | $188.88M | $312.70M | $462.36M |
Total Liabilities | $73.50M | $87.19M | $127.38M | $145.59M |
Cash & Equivalents | $26.69M | $66.73M | $130.03M | $167.14M |
Free Cash Flow OCF − CapEx | $-58.23M | $-67.95M | $-41.09M | $-121.95M |
Shares Outstanding | 8.16M | 7.86M | 7.58M | 148.75M |